Last updated: April 25, 2018

Valeant Pharmaceuticals Is Under S.E.C. Investigation

The beleaguered drug maker, already under scrutiny for its steep price increases, earlier canceled its fourth-quarter earnings report.










NYT > Home Page

Keywords: , , , ,


Readers Comments (0)


Sorry, comments are closed on this post.

Recent Posts

Have You Read?

Video News